Navigation Links
Abstract on Nasal Photodisinfection Therapy is Accepted for Presentation at the 19th Annual Scientific Conference of the Canadian Spine Society

Ondine Biomedical Inc., a company dedicated to the development of non-antibiotic, anti-infective therapies for a broad-spectrum of bacterial, viral and fungal infections and to combating increasing antimicrobial resistance, today announced that an abstract highlighting data resulting from the use of Ondine’s photodisinfection system has been accepted for presentation at the 19th Annual Scientific Conference of the Canadian Spine Society, February 27 – March 2, 2019, Toronto, Ontario, Canada.

Data will be highlighted from a quality improvement initiative running from 2009 at a major Vancouver health facility providing a pre-operative photodisinfection therapy to all patients undergoing spinal surgery.

The presentation will include long-term data on efficacy and cost-effectiveness of nasal antimicrobial photodisinfection therapy (aPDT) to reduce surgical site infections.

Details for the abstract presentation are as follows:

Title: Efficacy and Cost-Effectiveness of Photodynamic Therapy in Prevention of Surgical Site Infection Presenter: Daniel Banaszek, M.D. Principle Investigator: John Street, M.D., PhD Session Title: Presentation 54, Abstract 75 Date and Time: Friday, March 1, 2019, 8:30 AM, Concert Hall of Fairmont Royal York Hotel Abstract Contributors: Daniel Banaszek, M.D., University of British Columbia, Vancouver, BC, Canada; Tom Inglis, M.D., University of British Columbia, Vancouver, BC, Canada; Titus Wong, M.D., Vancouver Coastal Health; John Street, M.D., University of British Columbia, Vancouver, BC, Canada and Infection Control Program Surgeons (VSPS), Vancouver Spine Institute, Vancouver, BC, Canada. Location: Fairmont Royal York Hotel, Toronto, Ontario Canada

Ondine’s nasal photodisinfection system is a patented, first-in-class, light-activated antimicrobial therapy developed to eradicate a broad spectrum of nasal pathogens without promoting antibiotic resistance, including the ‘superbug’ methicillin-resistant Staphylococcus aureus (MRSA).

About Post-Surgical Site Infections

Surgical site infections (SSI’s) account for 15% of all hospital acquired infections and contribute substantially to morbidity and mortality each year. Up to 5% of surgical patients will develop an SSI in hospital, often resulting from Staphylococcus aureus infection. In many cases this virulent pathogen exhibits multidrug resistance making it increasingly difficult to treat. The evolution of antimicrobial resistance stems from the widespread use of antibiotics including inappropriate use in viral and non-susceptible infections. The relative risk of an SSI is up to 9 times greater in Staphylococcus carriers than in non-carriers. Furthermore, molecular epidemiology has demonstrated that the patient’s own nasal microflora are responsible for over 80% of postoperative infections. Existing approaches to eliminating nasal bacteria rely on expensive testing prior to surgery and/or prolonged antibiotic therapies. Compliance with these approaches is often poor, and the development of antibiotic resistance is a very real threat.

About Ondine Biomedical Inc.

Ondine Biomedical Inc. is dedicated to the development of non-antibiotic, anti-infective therapies for a broad-spectrum of bacterial, viral and fungal infections. Ondine’s antimicrobial program utilizes a platform technology called photodisinfection, a light-activated approach being developed to provide rapid antimicrobial efficacy and reduced risk of antibiotic resistance. Over 65 patents in 21 patent families have been granted or are pending covering various aspects of the technology. Ondine’s flagship nasal photodisinfection system has been deployed in Canada for several years, and other applications of the photodisinfection platform are under development, including SinuwaveTM, a photodisinfection product to treat chronic rhinosinusitis, and an endotracheal tube photodisinfection product designed to reduce the incidence of ventilator-associated pneumonia (VAP).    


Ondine Biomedical Inc.
Angelika Vance | 1.604.838.2702 | avance(at)

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related medicine technology :

1. Four Agenus Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) 2017 Annual Meeting
2. Allergan Presents Data From 21 Abstracts At The 2017 American Academy Of Dermatology Meeting In Orlando, FL
3. Johnson & Johnson Consumer Inc. Presents 21 Scientific Posters/Abstracts At The 2017 American Academy of Dermatology Annual Meeting
4. DaVita Clinical Research to Present 12 Abstracts at American Society of Nephrology Kidney Week 2016
5. Transformative Potential of Elektas High-field MR-guided Linear Accelerator Highlighted in Seven Abstracts at ESTRO 35
6. Neurocrine Biosciences Announces the Acceptance of Three Scientific Abstracts for Valbenazine (NBI-98854) at the 68th Annual Meeting of the American Academy of Neurology in Vancouver April 2016
7. AbbVies Commitment to Oncology Demonstrated at the 57th American Society of Hematology Annual Meeting with 61 Abstracts Evaluating Medicines in Several Blood Cancers
8. Benitec Biopharmas Abstract Accepted for Presentation at the AASLD Liver Meeting 2015
9. Allergan Anti-Infective Portfolio Highlighted in 13 Abstracts at IDWeek 2015
10. Emmaus Life Sciences to Present Abstract of Completed Phase 3 Sickle Cell Disease Trial at 9th Annual Sickle Cell and Thalassaemia Advanced Conference in London
11. Delcath Announces Acceptance Of Abstract For Presentation At RSNA Annual Meeting
Post Your Comments:
(Date:6/2/2020)... ... 2020 , ... As the leading human capital management organization ... is working with its corporate team, its consultants, and its healthcare partners to ... digital resources. Harmony’s leadership team recognized the extraordinary efforts of the healthcare community ...
(Date:6/2/2020)... (PRWEB) , ... June 02, 2020 , ... ... as well as screening tools, has strengthened its commitment to meeting today’s highest ... made for use in molecular pharmacology, early stages of drug discovery, screening of ...
(Date:5/30/2020)... ... May 29, 2020 , ... United Nations Foundation President ... announcement that it will terminate its relationship with the World Health Organization (WHO): ... terminate its relationship with the World Health Organization. Any move of this kind ...
Breaking Medicine Technology:
(Date:5/27/2020)... Ore. (PRWEB) , ... May ... ... May 2020 , Guest: Dr. Gerald Pollack, University of Washington Professor of ... Phase of Water: Beyond Solid, Liquid & Vapor ( ) , ...
(Date:5/26/2020)... ... May 26, 2020 , ... Sex educator, activist, humanitarian, and Wicked Pictures ... have just received the 2020 AASECT Audio Visual Award for jessica drake's Guide to ... of its kind to feature non-actors in its demonstrations and narratives and was produced ...
(Date:5/21/2020)... ... , ... In response to the Coronavirus pandemic, Industrial Magnetics, Inc.(IMI) has developed ... doors without using their hands or fingertips. , The new Arm-Pull attaches ... forearm, wrist or elbow when entering or exiting a room. , Perfect for public ...
(Date:5/21/2020)... CHICAGO (PRWEB) , ... May 21, 2020 , ... A ... receive a donation from the $5 million AbbVie COVID-19 Community Resilience Fund. The fund ... support the needs of their frontline homeless workers in service to vulnerable populations in ...
(Date:5/21/2020)... TAMPA, Fla. (PRWEB) , ... May 21, 2020 , ... ... redefined normal, there have been a lot of complications and adjustments, needless to say, ... to the highest level since the great depression it can be hard to escape ...
Breaking Medicine News(10 mins):